Phase IV Study: A Prospective Two-Site Study to Evaluate the Safety and Tolerance of Besivance Versus Vigamox Prophylactically Pre and Post Operatively in Subjects Undergoing Routine Cataract Surgery
The purpose of this study is to demonstrate that Besivance is equal to Vigamox in safety and tolerance when used prophylactically in subjects undergoing routine cataract surgery.
100 项与 Ophthalmology Consultants, Ltd. 相关的临床结果
0 项与 Ophthalmology Consultants, Ltd. 相关的专利(医药)
100 项与 Ophthalmology Consultants, Ltd. 相关的药物交易
100 项与 Ophthalmology Consultants, Ltd. 相关的转化医学